FDLI Introduction to Biologics and Biosimilars Law and Regulation - Regulation of Biological/Drug Development
Oct 14 2020
2:50 PM - 3:50 PM
Barbara Binzak Blumenfeld, Ph.D., shareholder in the firm's FDA & Biotechnology practice group, will present "Regulation of Biological/Drug Development" at the “Introduction to Biologics and Biosimilars Law and Regulation” course, sponsored by the Food and Drug Law Institute (FDLI). The October 14th presentation will cover investigational new drug applications, the oversight of clinical trials and interacting with FDA during biologic product development. Barbara has presented several times at this and other FDLI conferences and courses.
FDLI was founded in 1949 and is a nonprofit membership organization that engages food and drug law stakeholders in education and training. FDLI covers all industries that are regulated by FDA.